Price $3.08 |
Market Cap
70.7M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
40.3
|
P/B
0.81
|
P/S
1.54
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-22.7K
|
FCF
-1.2
|
|
Op. Margin
0.40%
|
Net Margin
4.10%
|
ROE
2.20%
|
ROI
-23.40%
|
|
ROA
1.70%
|
EPS Growth
109.80%
|
Current Ratio
7.6
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| IRIDEX Corporation (IRIX) | $2.63 | - | - | 47.2M | Strong Buy |
| ImmuCell Corporation (ICCC) | $5.80 | - | - | 43.3M | Strong Buy |
| American Renal Associates Hold (ARA) | $7.14 | - | - | 240.3M | Strong Buy |
| Biomerica, Inc. (BMRA) | $3.25 | - | - | 33.8M | Strong Buy |
| Lannett Company, Inc. (LCI) | $6.77 | - | - | 258.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
